Experiences of operational costs of HPV vaccine delivery strategies in Gavi-supported demonstration projects.

ABSTRACT: From 2012 to 2016, Gavi, the Vaccine Alliance, provided support for countries to conduct small-scale demonstration projects for the introduction of the human papillomavirus vaccine, with the aim of determining which human papillomavirus vaccine delivery strategies might be effective and sustainable upon national scale-up. This study reports on the operational costs and cost determinants of different vaccination delivery strategies within these projects across twelve countries using a standardized micro-costing tool. The World Health Organization Cervical Cancer Prevention and Control Costing Tool was used to collect costing data, which were then aggregated and analyzed to assess the costs and cost determinants of vaccination. Across the one-year demonstration projects, the average economic

SUBMITTER: Botwright S 

PROVIDER: S-EPMC5634534 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature